Intangible Assets

CRDF appears to have limited evidence of durable intangible assets because the provided metrics show deeply negative ROIC and ROCE, which implies any proprietary know-how is not translating into superior economic returns versus peers.

The absence of disclosed 5-year margin or return averages in the provided data weakens confidence that the company has sustained IP-led pricing power relative to better-established peers.

In a peer set of specialty biotech and diagnostics companies, stronger moat names typically show persistent gross-margin resilience or return premium from protected assets, while CRDF’s current profitability profile suggests those benefits are not yet durable.

Any regulatory or scientific differentiation is not visible in the supplied financial evidence, so the moat contribution from intangible assets remains weak until it is demonstrated through sustained margin and return outperformance.

Switching Costs

The very low asset turnover and negative returns suggest customers are not locked in by high switching frictions, because the business is not yet converting assets into durable retained revenue at peer-leading levels.

CRDF’s cash conversion cycle of 135.8 days indicates working-capital intensity rather than customer lock-in, which is more consistent with a weak switching-cost moat than with a strong one.

Compared with peers that benefit from embedded workflows, validated test adoption, or recurring clinical usage, the supplied data does not show evidence that customers would face material cost or risk to switch away from CRDF.

Without evidence of long-duration contracts, mission-critical integration, or retention metrics, switching costs appear low and therefore do not materially support pricing power or margin durability.

Network Effects

The provided metrics do not indicate any self-reinforcing user, data, or ecosystem loop, so there is no observable network effect supporting competitive durability.

Unlike platform or data-network peers where scale improves product value for all users, CRDF’s negative returns and weak asset efficiency do not show compounding adoption benefits.

The absence of evidence for growing installed base advantages, referral loops, or data accumulation means competitors likely can replicate customer acquisition and usage patterns.

Based on the supplied information, network effects are not a meaningful moat driver and do not appear to improve retention or pricing power versus peers.

Cost Advantage

CRDF’s negative ROIC and ROCE indicate it is not currently operating with a cost structure that converts into superior unit economics versus peers.

The extremely low asset turnover suggests the company is not extracting efficient revenue from its asset base, which argues against a durable cost advantage.

In peer comparison, firms with real cost advantages usually show structurally better margins, faster cash conversion, or higher capital productivity, none of which are evident in the supplied metrics.

The current financial profile is more consistent with a company still absorbing operating and commercialization costs than with one enjoying a repeatable cost edge.

Efficient Scale

The data do not show evidence that CRDF has reached an efficient-scale position where market size is limited enough to support durable excess returns.

Negative invested-capital returns and weak asset productivity suggest the company is not yet benefiting from scale economics that would deter peers or support sustained pricing power.

Compared with efficient-scale businesses that can spread fixed costs over a protected customer base, CRDF’s current metrics imply limited operating leverage and no clear structural barrier to entry.

The supplied information does not support the conclusion that the company occupies a scarce, hard-to-replicate niche with peer-dependent economics.

Overall Score

CRDF’s moat appears weak versus peers because the supplied financial metrics show negative capital returns, very low asset productivity, and no observable evidence of switching costs, network effects, cost advantage, or efficient scale that would sustain pricing power or retention over 5–10 years.